RBC Capital on Westlake Chemical (WLK): CFO appointment seen as 'positive' for HIP segment growth
April 21, 2026 9:57 AM
RBC Capital analyst Arun Viswanathan reiterated an Outperform rating and $145.00 price target on Westlake Chemical (NYSE: WLK)The analyst commented ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
